Skip to main content
. Author manuscript; available in PMC: 2012 Aug 20.
Published in final edited form as: Drug Deliv Transl Res. 2011 Feb 1;1(1):25–33. doi: 10.1007/s13346-010-0004-0

Fig. 5.

Fig. 5

Cellular uptake of FAM-labeled siRNA in various complexes and MNPs. a. Changes in FACS histograms indicative of siRNA-positive cells after 24 h of incubation following 4 h of treatment with different formulations. b. Bars represent quantitative analysis of FACS histograms in (a) to obtain the percentage of cells positive for FAM-siRNA. Data are expressed as the mean±SD (n=3; *p<0.05 vs free siRNA and PEI 1.8 complexes)